GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (FRA:TD5A) » Definitions » EV-to-FCF

Tandem Diabetes Care (FRA:TD5A) EV-to-FCF : -60.57 (As of Dec. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tandem Diabetes Care EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Tandem Diabetes Care's Enterprise Value is €2,106.4 Mil. Tandem Diabetes Care's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €-34.8 Mil. Therefore, Tandem Diabetes Care's EV-to-FCF for today is -60.57.

The historical rank and industry rank for Tandem Diabetes Care's EV-to-FCF or its related term are showing as below:

FRA:TD5A' s EV-to-FCF Range Over the Past 10 Years
Min: -1164   Med: -2.99   Max: 78987.75
Current: -59.52

During the past 13 years, the highest EV-to-FCF of Tandem Diabetes Care was 78987.75. The lowest was -1164.00. And the median was -2.99.

FRA:TD5A's EV-to-FCF is ranked worse than
100% of 373 companies
in the Medical Devices & Instruments industry
Industry Median: 28.76 vs FRA:TD5A: -59.52

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Tandem Diabetes Care's stock price is €30.17. Tandem Diabetes Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-1.772. Therefore, Tandem Diabetes Care's PE Ratio (TTM) for today is At Loss.


Tandem Diabetes Care EV-to-FCF Historical Data

The historical data trend for Tandem Diabetes Care's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care EV-to-FCF Chart

Tandem Diabetes Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 151.33 -748.54 105.85 359.80 -22.62

Tandem Diabetes Care Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.26 -22.62 -34.42 -41.43 -74.60

Competitive Comparison of Tandem Diabetes Care's EV-to-FCF

For the Medical Devices subindustry, Tandem Diabetes Care's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tandem Diabetes Care's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Tandem Diabetes Care's EV-to-FCF falls into.



Tandem Diabetes Care EV-to-FCF Calculation

Tandem Diabetes Care's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2106.366/-34.774
=-60.57

Tandem Diabetes Care's current Enterprise Value is €2,106.4 Mil.
Tandem Diabetes Care's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-34.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tandem Diabetes Care  (FRA:TD5A) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Tandem Diabetes Care's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=30.17/-1.772
=At Loss

Tandem Diabetes Care's share price for today is €30.17.
Tandem Diabetes Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.772.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Tandem Diabetes Care EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tandem Diabetes Care Business Description

Traded in Other Exchanges
Address
12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care Headlines

No Headlines